1018eTiP A phase I trial of RGT-61159, an oral MYB transcription factor inhibitor, for patients with relapsed/refractory (R/R) adenoid cystic carcinoma (ACC) and colorectal cancer (CRC).
Saved in:
| Title: | 1018eTiP A phase I trial of RGT-61159, an oral MYB transcription factor inhibitor, for patients with relapsed/refractory (R/R) adenoid cystic carcinoma (ACC) and colorectal cancer (CRC). |
|---|---|
| Authors: | Hanna, G.J.1 (AUTHOR), Sanz Garcia, E.2 (AUTHOR), Spira, A.I.3 (AUTHOR), Hilton, J.F.4 (AUTHOR), Ferrarotto, R.5 (AUTHOR), Zujun, L.6 (AUTHOR), Rodriguez, C.P.7 (AUTHOR), Swiecicki, P.L.8 (AUTHOR), Xi, S.9 (AUTHOR), Soulard, P.10 (AUTHOR), Wager, T.T.11 (AUTHOR), Walling, J.12 (AUTHOR), Ho, A.L.13 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS662-S663. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1587 |
